Blog: Blog2

GPCR News

Sep 30, 20221 min read

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..

October 2022 Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for...

Sep 30, 20221 min read

Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors

October 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance to the field of...

Sep 30, 20222 min read

Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair

October 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction in cardiac function and still...

Sep 30, 20221 min read

Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System

October 2022 "Pepducins are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs) that...